Microbial and cytopathological study of intrauterine contraceptive device users

Indian Journal of Medical Sciences

Volumn 58, Issue 9, 2004, Pages 394-399

  Agarwal, Krishna ^a,b   Sharma, Usha ^a   Acharya, Veena ^a  

^a SMS MEDICAL COLLEGE   (India)

^b R K Marbles Pvt Limited   (India)

Author keywords

Cytopathology; Infection; Intrauterine device

Indexed keywords

HEMOGLOBIN;

ABDOMINAL PAIN; ACTINOMYCES; ACTINOMYCOSIS; ADULT; ANAMNESIS; ANEMIA; ARTICLE; BACKACHE; BACTERIUM CULTURE; CARCINOGENESIS; CHI SQUARE TEST; COMPUTER SYSTEM; CONTROLLED STUDY; CYTOLOGY; CYTOPATHOLOGY; DYSMENORRHEA; DYSPAREUNIA; FAMILY PLANNING; FEMALE; FISHER EXACT TEST; FOLLOW UP; FUNGUS HYPHAE; GENITAL TRACT INFECTION; GRAM STAINING; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MENORRHAGIA; MICROORGANISM DETECTION; MYCOSIS; PATIENT COUNSELING; PH MEASUREMENT; PHYSICAL EXAMINATION; STUDENT T TEST; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EROSION; VAGINA DISCHARGE; VAGINITIS;

ADULT; BACTERIAL INFECTIONS; COPPER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES; PROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL DISEASES; UTERUS; VAGINAL SMEARS;

EID: 7244257365     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. th Ed. Baltimore: Lippincott Williams & Wilkins. 1999. p. 975-96.
2. Luthra UK, Mitra AB, Prabhakar AK, Agarwal SS, Bhatnagar P. Cytologic monitoring of women using copper containing intrauterine devices-Five year follow up study. Acta Cytologica 1982;26:619-22.
3. Gupta PK. Intrauterine contracetive devices: Vaginal cytology, pathologic changes and clinical implication. Acta Cytologica 1982;26:511-613.
4. Ferraz do Lago R, Simoes JA, Bahamondes L, Camargo RP, Perrotti M, Monteiro I. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections. Contraception. 2003;68:105-9.
5. Caliskan E, Ozturk N, Dilbaz BO, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8:150-5.
6. Farley TMM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. intrauterine devices and pelvic inflammatory diseases: An international perspective. Lancet 1992;339:785-8.
7. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 2001;CD001327.
8. International Institute of Population science. National Family Health Survey (NFHS II) 1998-99, Mumbai: 11PS; 2000.
9. Nayar M, Chandra M, Chitraratha K, Kumari Das S, Rai Chowdhary G. Incidence of actinomycetes infection in women using intrauterine contraceptive devices. Acta Cytol 1985;29:111-6.
10. Ashwani R, Bhale Rao, Shobha VS, Shroff RR, Purandare M. Cytology in CuT users. Jour Obstet Gynae Ind 1988;38:717-21.
11. Tosun I, Aydin F, Kaklikkaya N, Yazici Y. Frequency of bacterial vaginosis among women attending for intrauterine device insertion at an inner-city family planning clinic. Eur J Contracept Reprod Health Care 2003;8:135-8.
12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
13. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician 2003;68:1992-8.
14. th Ed. p. 447-86.